Gliben Vb 2/.2 Tablet

Oral tablet. Take exactly as prescribed, usually once daily with the first main meal (or as directed). Voglibose-containing combinations are generally taken with the first bite of food; do not skip meals to reduce risk of hypoglycaemia. Monitor blood glucose regularly.

Glimepiride is a sulfonylurea that stimulates the pancreas to release insulin and improves insulin utilization, lowering blood glucose. Voglibose is an alpha-glucosidase inhibitor that delays carbohydrate digestion/absorption in the intestine, reducing post-meal blood sugar spikes.

Risk of low blood sugar (higher if meals are skipped, with alcohol, strenuous exercise, or with other antidiabetics). Use with caution in kidney or liver impairment, elderly, malnourished, and those with adrenal/pituitary insufficiency. Not for type 1 diabetes or diabetic ketoacidosis. If severe hypoglycaemia occurs, take fast-acting glucose; with voglibose, treat lows with glucose/dextrose (not sucrose) as sucrose absorption is delayed. Stop and seek care for severe abdominal symptoms, jaundice, or allergic reactions.

Other antidiabetics (insulin, metformin, DPP-4 inhibitors) may increase hypoglycaemia risk; beta-blockers may mask hypoglycaemia symptoms; corticosteroids, thiazide diuretics, thyroid hormones, sympathomimetics may raise glucose; ACE inhibitors/MAO inhibitors may enhance glucose-lowering; warfarin (possible effect changes); fluoroquinolones may cause dysglycaemia; alcohol increases hypoglycaemia risk.

Store below 25°C in a dry place, protected from light and moisture. Keep in original strip and out of reach of children.

Glimy-VB 2/0.2 Tablet, Glim-V 2/0.2 Tablet, Glime-VB 2/0.2 Tablet, Glimepiride 2 mg + Voglibose 0.2 mg tablets (other brands), Amaryl-V 2/0.2 Tablet